Medtronic (MDT) Long-Term Deferred Tax (2014 - 2026)

Medtronic's Long-Term Deferred Tax history runs 13 years deep, the most recent figure standing at $4.0 billion for Q1 2026.

• In Q1 2026, Long-Term Deferred Tax rose 9.77% year-over-year to $4.0 billion; the TTM figure through Jan 2026 stood at $4.0 billion (up 9.77% YoY), while the FY2025 annual figure was $4.0 billion, up 10.47% from the prior year.
• Long-Term Deferred Tax came in at $4.0 billion for Q1 2026 at Medtronic, up from $3.9 billion in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $4.0 billion in Q2 2025 to a low of $3.3 billion in Q1 2022.
• A 5-year average of $3.6 billion and a median of $3.6 billion in 2024 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax slipped 0.03% in 2022 and increased 10.55% in 2025, its largest moves.
• Medtronic's Long-Term Deferred Tax stood at $3.4 billion in 2022, then gained by 2.33% to $3.4 billion in 2023, then advanced by 4.2% to $3.6 billion in 2024, then climbed by 7.98% to $3.9 billion in 2025, then rose by 2.85% to $4.0 billion in 2026.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $4.0 billion, $3.9 billion, and $3.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison